Cargando…

Screening for Potential Active Components of Fangji Huangqi Tang on the Treatment of Nephrotic Syndrome by Using Integrated Metabolomics Based on “Correlations Between Chemical and Metabolic Profiles”

As for traditional Chinese medicine (TCM) prescription, what puzzled researchers most was how to select proper chemical markers to represent the whole pharmacological action system. In this paper, an integrated metabolomic method was presented for a systematic discovery of potential active component...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiao, Zhou, Qi-Gang, Zhu, Xiao-Chai, Xie, Li, Cai, Bao-Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817620/
https://www.ncbi.nlm.nih.gov/pubmed/31695617
http://dx.doi.org/10.3389/fphar.2019.01261
_version_ 1783463460092248064
author Liu, Xiao
Zhou, Qi-Gang
Zhu, Xiao-Chai
Xie, Li
Cai, Bao-Chang
author_facet Liu, Xiao
Zhou, Qi-Gang
Zhu, Xiao-Chai
Xie, Li
Cai, Bao-Chang
author_sort Liu, Xiao
collection PubMed
description As for traditional Chinese medicine (TCM) prescription, what puzzled researchers most was how to select proper chemical markers to represent the whole pharmacological action system. In this paper, an integrated metabolomic method was presented for a systematic discovery of potential active components in Fangji Huangqi Tang (FHT), a well-known TCM prescription for nephrotic syndrome treatment, based on “correlations between chemical and metabolic profiles.” Firstly, a metabolomics study was carried out to select representative biomarkers of nephrotic syndrome. Then, after drug administration, the dynamic process of serum composition was investigated by the ultra-high performance liquid chromatography coupled with electrospray ionization–quadrupole–time of flight–mass spectrometry (UHPLC-ESI-Q-TOF-MS) technique to detect the prototypes and related metabolites of relative components from FHT. Pearson correlation analysis was finally used to find out the correlations between the endogenous metabolic spectrums and the chemical serum spectrums. As a result, 17 biomarkers for nephrotic syndrome indication were identified, and the main metabolic pathways of their concern included linoleic acid metabolism; cyanoamino acid metabolism; alpha-linolenic acid metabolism; glycine, serine, and threonine metabolism; arachidonic acid metabolism; and glycerophospholipid metabolism. Meanwhile, active components in FHT for nephrotic syndrome treatment were screened out, including (+)-tetrandrine demethylation, fenfangjine G hydrogenation, tetrandrine, N-methylfangchinoline, tetrandrine demethylation, fangchinoline, glycyrrhetic acid, astragaloside II alcohol dehydration, atractylenolide III demethylation + hydrogenation, atractylenolide III demethylation + hydrogenation, and licoricone-N-acetylcysteine conjugation. This study demonstrated a promising way to elucidate the active chemical material basis of TCM prescription.
format Online
Article
Text
id pubmed-6817620
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-68176202019-11-06 Screening for Potential Active Components of Fangji Huangqi Tang on the Treatment of Nephrotic Syndrome by Using Integrated Metabolomics Based on “Correlations Between Chemical and Metabolic Profiles” Liu, Xiao Zhou, Qi-Gang Zhu, Xiao-Chai Xie, Li Cai, Bao-Chang Front Pharmacol Pharmacology As for traditional Chinese medicine (TCM) prescription, what puzzled researchers most was how to select proper chemical markers to represent the whole pharmacological action system. In this paper, an integrated metabolomic method was presented for a systematic discovery of potential active components in Fangji Huangqi Tang (FHT), a well-known TCM prescription for nephrotic syndrome treatment, based on “correlations between chemical and metabolic profiles.” Firstly, a metabolomics study was carried out to select representative biomarkers of nephrotic syndrome. Then, after drug administration, the dynamic process of serum composition was investigated by the ultra-high performance liquid chromatography coupled with electrospray ionization–quadrupole–time of flight–mass spectrometry (UHPLC-ESI-Q-TOF-MS) technique to detect the prototypes and related metabolites of relative components from FHT. Pearson correlation analysis was finally used to find out the correlations between the endogenous metabolic spectrums and the chemical serum spectrums. As a result, 17 biomarkers for nephrotic syndrome indication were identified, and the main metabolic pathways of their concern included linoleic acid metabolism; cyanoamino acid metabolism; alpha-linolenic acid metabolism; glycine, serine, and threonine metabolism; arachidonic acid metabolism; and glycerophospholipid metabolism. Meanwhile, active components in FHT for nephrotic syndrome treatment were screened out, including (+)-tetrandrine demethylation, fenfangjine G hydrogenation, tetrandrine, N-methylfangchinoline, tetrandrine demethylation, fangchinoline, glycyrrhetic acid, astragaloside II alcohol dehydration, atractylenolide III demethylation + hydrogenation, atractylenolide III demethylation + hydrogenation, and licoricone-N-acetylcysteine conjugation. This study demonstrated a promising way to elucidate the active chemical material basis of TCM prescription. Frontiers Media S.A. 2019-10-22 /pmc/articles/PMC6817620/ /pubmed/31695617 http://dx.doi.org/10.3389/fphar.2019.01261 Text en Copyright © 2019 Liu, Zhou, Zhu, Xie and Cai http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Liu, Xiao
Zhou, Qi-Gang
Zhu, Xiao-Chai
Xie, Li
Cai, Bao-Chang
Screening for Potential Active Components of Fangji Huangqi Tang on the Treatment of Nephrotic Syndrome by Using Integrated Metabolomics Based on “Correlations Between Chemical and Metabolic Profiles”
title Screening for Potential Active Components of Fangji Huangqi Tang on the Treatment of Nephrotic Syndrome by Using Integrated Metabolomics Based on “Correlations Between Chemical and Metabolic Profiles”
title_full Screening for Potential Active Components of Fangji Huangqi Tang on the Treatment of Nephrotic Syndrome by Using Integrated Metabolomics Based on “Correlations Between Chemical and Metabolic Profiles”
title_fullStr Screening for Potential Active Components of Fangji Huangqi Tang on the Treatment of Nephrotic Syndrome by Using Integrated Metabolomics Based on “Correlations Between Chemical and Metabolic Profiles”
title_full_unstemmed Screening for Potential Active Components of Fangji Huangqi Tang on the Treatment of Nephrotic Syndrome by Using Integrated Metabolomics Based on “Correlations Between Chemical and Metabolic Profiles”
title_short Screening for Potential Active Components of Fangji Huangqi Tang on the Treatment of Nephrotic Syndrome by Using Integrated Metabolomics Based on “Correlations Between Chemical and Metabolic Profiles”
title_sort screening for potential active components of fangji huangqi tang on the treatment of nephrotic syndrome by using integrated metabolomics based on “correlations between chemical and metabolic profiles”
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817620/
https://www.ncbi.nlm.nih.gov/pubmed/31695617
http://dx.doi.org/10.3389/fphar.2019.01261
work_keys_str_mv AT liuxiao screeningforpotentialactivecomponentsoffangjihuangqitangonthetreatmentofnephroticsyndromebyusingintegratedmetabolomicsbasedoncorrelationsbetweenchemicalandmetabolicprofiles
AT zhouqigang screeningforpotentialactivecomponentsoffangjihuangqitangonthetreatmentofnephroticsyndromebyusingintegratedmetabolomicsbasedoncorrelationsbetweenchemicalandmetabolicprofiles
AT zhuxiaochai screeningforpotentialactivecomponentsoffangjihuangqitangonthetreatmentofnephroticsyndromebyusingintegratedmetabolomicsbasedoncorrelationsbetweenchemicalandmetabolicprofiles
AT xieli screeningforpotentialactivecomponentsoffangjihuangqitangonthetreatmentofnephroticsyndromebyusingintegratedmetabolomicsbasedoncorrelationsbetweenchemicalandmetabolicprofiles
AT caibaochang screeningforpotentialactivecomponentsoffangjihuangqitangonthetreatmentofnephroticsyndromebyusingintegratedmetabolomicsbasedoncorrelationsbetweenchemicalandmetabolicprofiles